clebopride has been researched along with Neoplasms in 1 studies
clebopride: antidopaminergic; RN given refers to parent cpd; structure
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clebopride was started at a dosage of 0." | 2.67 | A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients. ( Bleiberg, H; Lips, S; N'Koua Mbon, JB; Panzer, JM; Piccart, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleiberg, H | 1 |
| Piccart, M | 1 |
| Lips, S | 1 |
| Panzer, JM | 1 |
| N'Koua Mbon, JB | 1 |
1 trial available for clebopride and Neoplasms
| Article | Year |
|---|---|
A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Ci | 1992 |